Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Psoriatic arthritis.

Douglas Veale1, Oliver FitzGerald

  • 1Department of Rheumatology, St Vincent's University Hospital, Elm Park, Dublin, 4, Ireland.

Best Practice & Research. Clinical Rheumatology
|October 31, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Composite outcome measures that successfully differentiate active treatments from placebo in psoriatic arthritis trials: a GRAPPA-OMERACT systematic review and network meta-analysis.

Annals of the rheumatic diseases·2026
Same author

Molecular Biomarkers for Predicting Treatment Response in Psoriatic Arthritis.

Rheumatic diseases clinics of North America·2026
Same author

Definition of the terms used to describe psoriatic disease datasets: a HIPPOCRATES initiative.

Therapeutic advances in musculoskeletal disease·2026
Same author

The protocol for a patient-driven online prospective European observational cohort aiming to determine risk factors for the development of psoriatic arthritis among people living with psoriasis: the HIPPOCRATES Prospective Observational Study.

Therapeutic advances in musculoskeletal disease·2026
Same author

The path to interception in psoriatic disease: from conceptual clarity to clinical translation.

The Lancet. Rheumatology·2026
Same author

GRAPPA 2024: Key Project Advances.

The Journal of rheumatology·2025
Same journal

The young adult with Juvenile Idiopathic Arthritis (JIA): A clinical review of transition, complications, and psychosocial management.

Best practice & research. Clinical rheumatology·2026
Same journal

Impact of fatigue on rheumatic diseases: Current perspectives.

Best practice & research. Clinical rheumatology·2026
Same journal

Pneumocystis prophylaxis in rheumatic disease.

Best practice & research. Clinical rheumatology·2026
Same journal

Cutaneous manifestations in myositis syndromes.

Best practice & research. Clinical rheumatology·2026
Same journal

Systemic sclerosis: A comprehensive systematic review of global epidemiology, sex and ethnic disparities, disease burden, and organ-specific involvement.

Best practice & research. Clinical rheumatology·2026
Same journal

Alopecia across the spectrum of rheumatic disease.

Best practice & research. Clinical rheumatology·2026
See all related articles

Psoriatic arthritis (PsA) involves skin and joints due to shared antigens. Research explores common mechanisms across PsA subtypes, suggesting a single disease with varied presentations.

Area of Science:

  • Rheumatology
  • Immunology
  • Dermatology

Background:

  • Psoriatic arthritis (PsA) is a prevalent inflammatory condition affecting approximately 15% of early synovitis clinic patients.
  • PsA is characterized by distinct organ involvement, primarily affecting the skin, synovial tissue, and entheseal attachment sites.
  • The localized inflammation suggests shared antigens or cells driving the immune response in these specific areas.

Purpose of the Study:

  • To investigate the evidence for common pathogenic mechanisms in both skin and joint tissues in psoriatic arthritis.
  • To explore the potential for similar underlying mechanisms across the diverse subtypes of psoriatic arthritis.
  • To evaluate whether psoriatic arthritis represents a single disease entity with varied clinical manifestations.

Main Methods:

Related Experiment Videos

  • Review and synthesis of existing scientific literature on psoriatic arthritis pathogenesis.
  • Analysis of evidence supporting shared immunological pathways in affected tissues.
  • Exploration of genetic and cellular factors contributing to disease presentation.

Main Results:

  • Evidence suggests common pathogenic mechanisms operate in the skin and joints of PsA patients.
  • The findings support the hypothesis that PsA may share similar underlying mechanisms across its various clinical subtypes.
  • The restricted organ involvement points towards specific antigens or cellular interactions driving the inflammatory process.

Conclusions:

  • Psoriatic arthritis is likely a single disease entity presenting with diverse clinical manifestations.
  • Further comprehensive genetic and mechanistic studies are necessary to definitively confirm this conclusion.
  • Understanding shared pathways is crucial for developing targeted therapies for PsA.